Citi has downgraded its rating from Buy to Hold and has lowered its price target from $17 to $12 on Sun Healthcare Group SUNH.
According to Citi, “We are lowering our investment rating on SUNH from Buy/High Risk (1H) to Hold/Speculative Risk (2S). Despite the recent sell-off in the shares from last Friday's F'12 Medicare proposal, we see balanced risk/reward at best over the next 12months. We have a high level of confidence in the quality and capabilities of SUNH management, but the specter of sizable a MDCR reimbursement cut materially diminishes our confidence and visibility for the nursing home sector at large.”
SUNH closed yesterday at $11.59.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorDowngradesPrice TargetAnalyst RatingsCitiHealth CareHealth Care FacilitiesSun Healthcare Group Inc.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in